{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:28:27Z","timestamp":1787164107083,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360472"],"award-info":[{"award-number":["82360472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","award":["jxsq2023201077"],"award-info":[{"award-number":["jxsq2023201077"]}],"id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB20609"],"award-info":[{"award-number":["20232BAB20609"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019976","name":"Science and Technology Bureau of Jiaxing City","doi-asserted-by":"publisher","award":["2022-KJZC-008"],"award-info":[{"award-number":["2022-KJZC-008"]}],"id":[{"id":"10.13039\/501100019976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10495-026-02395-y","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:29:00Z","timestamp":1783780140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLI2 confers ferroptosis resistance in bladder cancer by transcriptionally upregulating PRDX1"],"prefix":"10.1007","volume":"31","author":[{"given":"Yuyang","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1322-6768","authenticated-orcid":false,"given":"Xiao-Bin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2395_CR1","unstructured":"World Cancer Research Fund International Bladder Cancer Statistics. www.wcrf.org\/ cancer-trends\/bladder-cancer-statistics\/"},{"issue":"1","key":"2395_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medsci8010015","volume":"8","author":"K Saginala","year":"2020","unstructured":"Saginala K, Barsouk A, Aluru JS et al (2020) Epidemiol- ogy of bladder cancer. Med Sci 8(1):1\u201312. www.mdpi.com\/2076-3271\/8\/1\/15","journal-title":"Med Sci"},{"issue":"8","key":"2395_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/medicina57080749","volume":"57","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M (2021) Bladder Cancer: Current Challenges and Future Directions. Med (Kaunas) 57(8):749. https:\/\/doi.org\/10.3390\/medicina57080749. PMID: 34440955; PMCID: PMC8402079","journal-title":"Med (Kaunas)"},{"key":"2395_CR4","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W (2023) Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat 68:100938 Epub 2023 Feb 9. PMID: 36774746","journal-title":"Drug Resist Updat"},{"issue":"4","key":"2395_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8. Epub 2021 Jan 25. PMID: 33495651; PMCID: PMC8142022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2395_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2. PMID: 32015325; PMCID: PMC6997353","journal-title":"Cell Death Dis"},{"key":"2395_CR7","doi-asserted-by":"publisher","first-page":"1043283","DOI":"10.3389\/fphar.2022.1043283","volume":"13","author":"F Zeng","year":"2022","unstructured":"Zeng F, Lan Y, Wang N, Huang X, Zhou Q, Wang Y, Ferroptosis (2022) A new therapeutic target for bladder cancer. Front Pharmacol 13:1043283. https:\/\/doi.org\/10.3389\/fphar.2022.1043283. PMID: 36408230; PMCID: PMC9669411","journal-title":"Front Pharmacol"},{"issue":"1","key":"2395_CR8","first-page":"100","volume":"57","author":"L Xia","year":"2020","unstructured":"Xia L, Bouamar H, Gu X, Zeballos C, Qin T, Wang B, Zhou Y, Wang Y, Yang J, Zhu H, Zhang W, Houghton PJ, Sun LZ (2020) Gli2 mediates the development of castration-resistant prostate cancer. Int J Oncol 57(1):100\u2013112 Epub 2020 Apr 13. PMID: 32319599; PMCID: PMC7252461","journal-title":"Int J Oncol"},{"issue":"1","key":"2395_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41419-025-07564-6","volume":"16","author":"W Zhu","year":"2025","unstructured":"Zhu W, Sun J, Jing F, Xing Y, Luan M, Feng Z, Ma X, Wang Y, Jia Y (2025) GLI2 inhibits cisplatin sensitivity in gastric cancer through DEC1\/ZEB1 mediated EMT. Cell Death Dis 16(1):204. https:\/\/doi.org\/10.1038\/s41419-025-07564-6. PMID: 40133270; PMCID: PMC11937514","journal-title":"Cell Death Dis"},{"issue":"7","key":"2395_CR10","doi-asserted-by":"publisher","first-page":"110311","DOI":"10.1016\/j.jbc.2025.110311","volume":"301","author":"RE Vera","year":"2025","unstructured":"Vera RE, Fernandez-Barrena MG, Falero JM, Kwon JY, Garza RA, Sigafoos AN, Ross MD, Toruner MD, Toruner M, Tolosa EJ, Almada LL, Huang H, Brekken RA, Fernandez-Zapico ME (2025) Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2-collagen I signaling. J Biol Chem 301(7):110311 Epub 2025 May 29. PMID: 40449600; PMCID: PMC12256325","journal-title":"J Biol Chem"},{"key":"2395_CR11","doi-asserted-by":"publisher","unstructured":"Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Ikram MS, Quinn AG, Philpott MP, Frischauf AM, Aberger F (2004) The zinc-finger transcription factor GLI2 antagonizes contact inhibition and differentiation of human epidermal cells. Oncogene. ;23(6):1263-74. https:\/\/doi.org\/10.1038\/sj.onc.1207240. PMID: 14691458","DOI":"10.1038\/sj.onc.1207240"},{"issue":"1","key":"2395_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/jcmm.12955","volume":"21","author":"C Ding","year":"2017","unstructured":"Ding C, Fan X, Wu G (2017) Peroxiredoxin 1 - an antioxidant enzyme in cancer. J Cell Mol Med 21(1):193\u2013202. https:\/\/doi.org\/10.1111\/jcmm.12955. Epub 2016 Sep 21. PMID: 27653015; PMCID: PMC5192802","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2395_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11427-023-2425-2","volume":"67","author":"X Fan","year":"2024","unstructured":"Fan X, Liu F, Wang X, Wang Y, Chen Y, Shi C, Su X, Tan M, Yan Q, Peng J, Shao J, Xiong Y, Lin A (2024) LncFASA promotes cancer ferroptosis via modulating PRDX1 phase separation. Sci China Life Sci 67(3):488\u2013503. https:\/\/doi.org\/10.1007\/s11427-023-2425-2. Epub 2023 Nov 10. PMID: 37955780","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2395_CR14","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41598-022-14554-7","volume":"12","author":"L Luo","year":"2022","unstructured":"Luo L, Yao X, Xiang J, Huang F, Luo H (2022) Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma. Sci Rep 12(1):10007. https:\/\/doi.org\/10.1038\/s41598-022-14554-7. PMID: 35705729; PMCID: PMC9200861","journal-title":"Sci Rep"},{"key":"2395_CR15","doi-asserted-by":"publisher","unstructured":"Gao L, Meng J, Yue C, Wu X, Su Q, Wu H, Zhang Z, Yu Q, Gao S, Fan S, Zuo L (2021) Integrative analysis the characterization of peroxiredoxins in pan-cancer. Cancer Cell Int. ;21(1):366. https:\/\/doi.org\/10.1186\/s12935 021-02064-x. PMID: 34246267; PMCID: PMC8272277","DOI":"10.1186\/s12935"},{"key":"2395_CR16","doi-asserted-by":"publisher","unstructured":"Ranstam J, Cook JA (2017) Kaplan-Meier curve. Br J Surg. ;104(4):442. https:\/\/doi.org\/10.1002\/bjs.10238. PMID: 28199017","DOI":"10.1002\/bjs.10238"},{"issue":"13","key":"2395_CR17","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.7150\/ijbs.99804","volume":"20","author":"Y Song","year":"2024","unstructured":"Song Y, Wang X, Sun Y, Yu N, Tian Y, Han J, Qu X, Yu X (2024) PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer. Int J Biol Sci 20(13):5070\u20135086. https:\/\/doi.org\/10.7150\/ijbs.99804. PMID: 39430237; PMCID: PMC11489176","journal-title":"Int J Biol Sci"},{"key":"2395_CR18","doi-asserted-by":"publisher","first-page":"101274","DOI":"10.1016\/j.drup.2025.101274","volume":"82","author":"T Yang","year":"2025","unstructured":"Yang T, Zhang S, Nie K, Cheng C, Peng X, Huo J, Zhang Y (2025) ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion. Drug Resist Updat 82:101274. https:\/\/doi.org\/10.1016\/j.drup.2025.101274. Epub 2025 Jul 12. PMID: 40680452","journal-title":"Drug Resist Updat"},{"key":"2395_CR19","doi-asserted-by":"publisher","first-page":"101639","DOI":"10.1016\/j.bbrep.2024.101639","volume":"37","author":"C Fan","year":"2024","unstructured":"Fan C, Yuan S, Zhang Y, Nie Y, Xiang L, Luo T, Xi Q, Zhang Y, Gu Z, Wang P, Zhou H (2024) Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells. Biochem Biophys Rep 37:101639. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101639. PMID: 38288281; PMCID: PMC10823101","journal-title":"Biochem Biophys Rep"},{"key":"2395_CR20","doi-asserted-by":"publisher","unstructured":"Kaufman DS (2006) Challenges in the treatment of bladder cancer. Ann Oncol. ;17 Suppl 5:v106-12. https:\/\/doi.org\/10.1093\/annonc\/mdj963. PMID: 16807436","DOI":"10.1093\/annonc\/mdj963"},{"key":"2395_CR21","doi-asserted-by":"publisher","unstructured":"Herr H, Soloway M, Cisplatin (2022) Neoadjuvant Chemotherapy and Bladder Cancer. Urology. ;159:2\u20135. https:\/\/doi.org\/10.1016\/j.urology.2021.10.017. Epub 2021 Nov 1. PMID: 34736977","DOI":"10.1016\/j.urology.2021.10.017"},{"issue":"13","key":"2395_CR22","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.3390\/ijms23137241","volume":"23","author":"R Ali","year":"2022","unstructured":"Ali R, Aouida M, Alhaj Sulaiman A, Madhusudan S, Ramotar D (2022) Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. Int J Mol Sci 23(13):7241. https:\/\/doi.org\/10.3390\/ijms23137241. PMID: 35806243; PMCID: PMC9266583","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2395_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S (2022) Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol 15(1):174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3. PMID: 36482419; PMCID: PMC9733270","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2395_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","volume":"26","author":"D Fu","year":"2021","unstructured":"Fu D, Wang C, Yu L, Yu R (2021) Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling. Cell Mol Biol Lett 26(1):26. https:\/\/doi.org\/10.1186\/s11658-021-00271-y. PMID: 34098867; PMCID: PMC8186082","journal-title":"Cell Mol Biol Lett"},{"key":"2395_CR25","doi-asserted-by":"crossref","unstructured":"Ni M, Zhou J, Zhu Z, Xu Q, Yin Z, Wang Y, Zheng Z, Zhao H (2023) Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe2\u2009+\u2009accumulation. Phytomedicine. ;112:154701. doi: 10.1016\/j.phymed.2023.154701. Epub 2023 Feb 4. PMID: 36773431","DOI":"10.1016\/j.phymed.2023.154701"},{"issue":"1","key":"2395_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12920-025-02108-5","volume":"18","author":"Y Gong","year":"2025","unstructured":"Gong Y, Li R, Zhang R, Jia L (2025) USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC. BMC Med Genomics 18(1):39. https:\/\/doi.org\/10.1186\/s12920-025-02108-5. PMID: 40011884; PMCID: PMC11866681","journal-title":"BMC Med Genomics"},{"key":"2395_CR27","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.gendis.2022.05.010","volume":"9","author":"B Yu","year":"2022","unstructured":"Yu B, Gu D, Zhang X, Liu B, Xie J (2022) Regulation of pancreatic cancer metastasis through the Gli2-YAP1 axis via regulation of anoikis. Genes Dis 9:1427\u20131430","journal-title":"Genes Dis"},{"key":"2395_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.canlet.2019.10.044","volume":"469","author":"C Seidl","year":"2020","unstructured":"Seidl C, Panzitt K, Bertsch A, Brcic L, Schein S, Mack M, Leithner K, Prinz F, Olschewski H, Kornmueller K, Hrzenjak A (2020) MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2. Cancer Lett 469:266\u2013276 Epub 2019 Nov 5. PMID: 31697978","journal-title":"Cancer Lett"},{"key":"2395_CR29","doi-asserted-by":"publisher","unstructured":"Zheng J, Conrad M (2025) Ferroptosis: when metabolism meets cell death. Physiol Rev. ;105(2):651\u2013706. https:\/\/doi.org\/10.1152\/physrev.00031.2024. Epub 2024 Dec 11. PMID: 39661331","DOI":"10.1152\/physrev.00031.2024"},{"key":"2395_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.freeradbiomed.2023.11.009","volume":"210","author":"X Guan","year":"2024","unstructured":"Guan X, Ruan Y, Che X, Feng W (2024) Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future. Free Radic Biol Med 210:120\u2013129 Epub 2023 Nov 15. PMID: 37977211","journal-title":"Free Radic Biol Med"},{"key":"2395_CR31","doi-asserted-by":"publisher","first-page":"1625604","DOI":"10.3389\/fphar.2025.1625604","volume":"16","author":"L Guan","year":"2025","unstructured":"Guan L, Geng Y, Wang Y, Niu MM, Shi K (2025) Discovery of novel and potent celastrol derivatives as PRDX1 inhibitors for cancer therapy through structure-based virtual screening. Front Pharmacol 16:1625604. https:\/\/doi.org\/10.3389\/fphar.2025.1625604. PMID: 40771925; PMCID: PMC12325182","journal-title":"Front Pharmacol"},{"key":"2395_CR32","doi-asserted-by":"publisher","unstructured":"Li W, Wu B, Qian H, Zhang G, Wang X, Li X (2026) The YY1-KIF15-PRDX1 axis promotes gastric cancer progression by inducing mitochondrial ROS imbalance. Oncogene 30. https:\/\/doi.org\/10.1038\/s41388-026-03722-y Epub ahead of print. PMID: 41912772","DOI":"10.1038\/s41388-026-03722-y"},{"issue":"2","key":"2395_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4046\/trd.2013.75.2.59","volume":"75","author":"KE Hwang","year":"2013","unstructured":"Hwang KE, Park C, Seol CH, Hwang YR, Hwang JS, Jung JW, Choi KH, Jeong ET, Kim HR (2013) Elevated prx1 provides resistance to docetaxel, but is not associated with predictive significance in lung cancer. Tuberc Respir Dis (Seoul) 75(2):59\u201366 Epub 2013 Aug 30. PMID: 24023558; PMCID: PMC3766810","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"1","key":"2395_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1186\/s12885-019-6046-x","volume":"19","author":"H Zhu","year":"2019","unstructured":"Zhu H, Tao X, Zhou L, Sheng B, Zhu X, Zhu X (2019) Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT. BMC Cancer 19(1):865. https:\/\/doi.org\/10.1186\/s12885-019-6046-x. PMID: 31470801; PMCID: PMC6716838","journal-title":"BMC Cancer"},{"key":"2395_CR35","doi-asserted-by":"publisher","unstructured":"Kalinina EV, Berezov TT, Shtil\u2019 AA, Chernov NN, Glazunova VA, Novichkova MD, Nurmuradov NK (2012) Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation. Bull Exp Biol Med. ;153(6):878\u2009\u2013\u200981. English, Russian. https:\/\/doi.org\/10.1007\/s10517-012-1849-7. PMID: 23113308","DOI":"10.1007\/s10517-012-1849-7"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02395-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02395-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02395-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:56Z","timestamp":1787162576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02395-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02395-y","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest, financial or personal, that could have influenced the work reported in this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"191"}}